Corvite FE By Vertical Pharmaceuticals Overview & Drug Interactions

Check For Interactions With Corvite FE

Supplement: Corvite FE by Vertical Pharmaceuticals

Corvite FE Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Corvite FE by Vertical Pharmaceuticals

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 {Tablet(s)}
Maximum serving Sizes:
1 {Tablet(s)}

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Sumalate
25 mg
Iron
Ferronyl Carbonyl Iron
125 mg
Iron
Folate
1 mg
Folate
Vitamin C
160 mg
Vitamin C
Calcium Threonate
5 mg
Calcium
Vitamin B6
10 mg
Vitamin B6
Vitamin B12
15 mcg
Vitamin B12
Vitamin D3
1000 IU
Vitamin D
Zinc
25 mg
Zinc
Magnesium
15 mg
Magnesium

Other Ingredients:
Black Iron Oxide
Citric Acid
Croscarmellose Sodium
Di Calcium Phosphate
Ethyl Cellulose
FD&C Red #40 Lake
fumed Silica
Gum Arabic
Hydroxypropyl Cellulose
Hypromellose
Magnesium Stearate
Microcrystalline Cellulose
Polyethylene Glycol
Polysorbate 80
PVP K30
Talc
Titanium Dioxide
Tripotassium Citrate
Vegetable oil


Label Statments:


General Statements
- PRESCRIBING INFORMATION DESCRIPTION Red, oval bisected tablets embossed "VP042".
- CLINICAL PHARMCOLOGY Iron is an essential component in the formation of hemoglobin. Adequate amounts of iron are necessary for effective erythropoiesis. Iron also serves as a cofactor of several essential enzymes, including cytochromes that are involved in electron transport. Folic acid is required for nucleoprotein synthesis and the maintenance of normal erythropoiesis. Folic acid is converted in the liver and plasma to its metabolically active form, tetrahydrofolic acid, by dihydrofolate reductase. Vitamin B12 is required for the maintenance of normal erythropoiesis, nucleoprotein and myelin synthesis, cell reproduction and normal growth. Intrinsic factor, a glycoprotein secreted by the gastric mucosa, is required for active absorption of vitamin B12 from the gastrointestinal tract.
- Rx Only.
Precautions
- WARNINGS Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
- Folic Acid Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia.
- ADVERSE REACTIONS Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient.
- Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
- OVERDOSAGE The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanossi, lassitude, seizures, shock and coma.
- WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
- PRECAUTIONS General Do not exceed recommended dose. The type of anemia and the underlying cause or causes should be determined before starting therapy with CORVITE(R) FE. Since the anemia may be a result of a sytemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.
- Pediatric Use Safety and effectiveness in pediatric patients have not been established.
- Geriatric Use Clinical studies on this product have not been performed in subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious.
- KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN.
Brand IP Statement(s)
- HOW SUPPLIED CORVITE(R) FE available in carton unit dose pack of 30 (6 child resistant blister cards of 5 tablets per card).
- US Patent No. 5,516,925 US Patent No. 6,716,814 US Patent No. 7,838,042 US Patent No. 6,706,901 Other Patents Pending
- INDICATIONS AND USAGE CORVITE(R) FE is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.
- CONTRAINDICATIONS CORVITE(R) FE is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy.
- DimaCal and TRAACS are registered trademarks of Albion Laboratories, Inc. Malates covered by U.S. Patent 6,706,904, chelate covered by U.S. Patent 7,838,042; and patents pending.
- Sumalate (ferrous asparto glycinate) is a trademark of Albion International, Inc., Clearfield, Utah.
Suggested/Recommended/Usage/Directions
- DOSAGE AND ADMINISTRATION Usual adult dose is 1 tablet daily, or as prescribed by a physician.
General
- CFELB021101
Storage
- STORAGE Store at controlled room temperature 15(0)-30(0)C (59(0)-86(0)F) [See USP]. Protect from light, moisture and excessive heat. Dispense in a tight, light resistant container as defined in the USP using a child-resistant closure.

Brand Information

See all products by this brand

Manufactured for:
Name Vertical Pharmaceuticals, Inc.
City Sayreville
State NJ
ZipCode 08872

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.